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INTRODUCTION
Biodegradable polymeric microspheres as an injectable 
depots for proteins or peptides have been extensively 
investigated for the past decades [1-7]. Poly(D,L-
lactideco-glycolide) (PLGA), a biocompatible and 
biodegradable copolymer, has been mostly used for 
delivering protein drugs in a sustained manner [1-3]. 
Various protein drugs were microencapsulated within 
PLGA microspheres using different formulation methods 
[4-7]. The most commonly used methods for protein 
drug encapsulation in polymeric microparticles include 
solvent extraction or evaporation from a water/oil/water 
(W1/O/W2)- dispersion, coacervation, and spray drying. 
Microencapsulation techniques, however, involve several 
steps that are detrimental to protein stability, such as 
exposure of proteins to aqueous/ organic interface, shear 
induced stress during emulsification, and freeze drying. 
Under such circumstances, physical destabilization 
resulting in formation of protein aggregates has been 
observed. A routine observation made with protein 
loaded microspheres showing incomplete release of the 
protein may very well be due to the insoluble aggregates 
generated during the encapsulation process. In the case 
with bioactive proteins, significant loss of activity has also 
been reported. During the release, surface adsorption of 
protein on microspheres and/or an acidic microclimate 
generated due to polymer degradation may also cause 
protein instability. One strategy to overcome these 
processing problems is to load the drug into preformed 
porous microspheres. Recently, a new formulation, 
porous microspheres showing the large porous surface 
and interconnecting pores interior, has drawn attention 
for protein delivery [5-10]. Protein could be entrapped 
into pores of porous microspheres by a solution 
immersing method. Advantages of this method include 
that it is a single step not requiring extended shearing/
stirring rates, sonification, or high temperatures. The 
method is characterized by the absence of an aqueous/
organic interface which is detrimental to protein structure 
and function [11-15].  In this study, instead of neutralizing 
the acidic microclimate, a strategy to avoid acid build-
up was devised. Aqueous/organic interface was avoided 
and protein biological activity could be protected during 
loading process. The porous PLGA microspheres were 
fabricated by an emulsion solvent evaporation technique 
using PEG as an extractable porogen and loaded 
with protein by suspending them protein solution, and 




with a lactide/glycolide (L/G) ratio of 50:50 (Mw 48 
kDa, inherent viscosity 0.67 dl/g) were purchased 
from Boehringer ingelheim Germany. Hen egg white 
lysozyme, Micrococcus lysodeikticus, Polyvinyl alcohol 
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ABSTRACT
Poly(D,L-lactic-co-glycolic acid)  has been extensively used as a controlled release carrier for drug delivery due to its good 
biocompatibility, biodegradability, and mechanical strength. In this study, porous PLGA microspheres were fabricated by 
an emulsion-solvent evaporation technique using poly ethylene glycol (PEG) as an extractable porogen and loaded with 
protein (lysozyme) by suspending them in protein solution. For controlled release of protein, porous microspheres containing 
lysozyme were treated with water-miscible solvents in aqueous phase for production of pore-closed microspheres. The 
surface morphology of microspheres were investigated using scanning electron microscopy (SEM) for confirmation of its 
porous microstructure structure. Protein property after release was observed by enzymatic activity assay. The pore-closing 
process resulted in nonporous microspheres which exhibited sustained release patterns over an extended period.
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(PVA) (87–89% hydrolysed, Mw of 23000–75000 Da) 
and Bicinchoninic acid (BCA) protein assay kit were 
purchased from Sigma-Aldrich. Poly(ethylene glycol)
(PEG) (Mw 10000) was purchased from Aldrich. Unless 
specified, all other chemicals were of analytical grade 
and purchased from Aldrich.
Preparation of porous PLGA microspheres: The 
porous microspheres were prepared by a single oil-
in-water emulsion method with PEG as pore formers. 
Briefly, a polymer mixture of PEG and PLGA with varying 
weight ratios was dissolved in methylene chloride 
(MC). The polymer solution was emulsified in 100 ml of 
deionized water containing 0.5% (w/v) (PVA) for 90 s at 
10000 rpm using a homogenizer. The resultant emulsion 
solution was placed in a hood under a magnetic stirring 
condition for 6 h, allowing the solvent to evaporate. The 
hardened microspheres were centrifuged for 10 min at 
10000 rpm, washed three times with deionized water 
and then freeze-dried.
Encapsulation of protein within porous PLGA 
microspheres: The porous PLGA microspheres were 
loaded with lysozyme by suspending them in into 1 ml 
of lysozyme solution (in 10 mM phosphate buffer, pH 
7.4) and gently shaking for 6 h at 4°C. The lysozyme-
loaded microspheres were separated by centrifugation 
and freeze- dried.
Pore-closing of lysozyme loaded porous micro-
spheres in aqueous condition: Blank porous PLGA 
microspheres were dispersed in deionized water by 
vortexing. Water was then added into the suspension 
as a water miscible solvent while mixing. The final 
concentration of water miscible solvents in 2 ml of solution 
was varied from 0% to 30% (v/v). The pore-closing 
process was terminated by addition of excess water and 
further incubation for 1 h. The resultant microspheres 
were centrifuged, washed with deionized water and 
freeze-dried. In the case of lysozyme incorporated 
porous microspheres, acetonitrile, Dimethylformamide 
(DMF) were used as the water miscible solvent, in place 
of ethanol.
Morphology of PLGA microspheres:  The microspheres 
were coated with platinium by using model Sputter Coater 
(E-1030, 0-35mA DC, Pt-Pd 8:2, HITACHI, Japan). 
Surface morphology and internal structure of porous and 
pore closed microspheres were examined by scanning 
electron microscopy (FE-SEM, S-4300 SE, HITACHI, 
Japan). The average sizes of the microspheres and their 
pores were determined by measuring the diameters of at 
least 40 of each microsphere and the pore within them.
Total protein content determination: The encapsula-
tion efficiency of lysozyme was determined using the 
dimethyl sulfoxide (DMSO)/sodium hydroxide (NaOH)/
sodium dodecyl sulfate (SDS) method that described 
in the literature [15] with a slight modification. The 
microcapsules, after solidification and washing in distilled 
water, were freeze-dried and stored at 4°C, prior to the 
measurement. Microcapsules (10 mg) were placed into a 
test tube to which DMSO (0.2 ml) was added to dissolve 
the polymer portion of the microcapsules. Then, 0.8 ml of 
0.05 N NaOH solution containing 0.5% SDS was added 
to allow solubilization of the protein and hydrolysis of 
PLGA. The resulting mixture was sonicated for 90 min 
at 25°C and centrifuged at 10000 rpm for 10 min. The 
clear supernatant (25 μl) was transferred into a 96-well 
microplate. The protein concentration was determined 
with Bicinchoninic acid assay (BCA protein assay 
reagent kit), by colorimetric analysis at 562 nm with a 
fluorescence multi-Detection reader (Synergy HT, USA). 
The encapsulation efficiency (E) was defined as follows:
In vitro release study: In vitro protein release from 
microspheres was evaluated by an in vitro dissolution 
test. Amounts of 20 mg of microspheres were dispersed 
in 4 ml PBS (pH 7.4) containing 0.01% NaN3, the 
suspensions were kept at 37°C and shaken moderately. 
At predetermined time intervals, 1 ml of medium, from 
each sample, were removed and replaced with fresh PBS 
buffer. The amount of protein released was determined 
at 562 nm by Bicinchoninic acid assay (BCA).
Degradation study of PLGA microspheres: Pre-
weighed PLGA microspheres (about 10 mg) were placed 
in individual test tubes containing 4 ml of phosphate 
buffered saline (PBS, 0.1 M, pH 7.4). The tubes were 
kept in an incubator that was maintained at 37°C. At 
predetermined degradation intervals, the microspheres 
were collected by centrifugation, washed with distilled 
water to remove residual buffer salts, and dried to 
constant weight in vacuum desiccators. The degradation 
medium was collected to characterize the pH change 
during the degradation process. The surface morphology 
of degraded PLGA microspheres was analyzed using 
SEM at 12 kV.
RESULTS AND DISCUSSION
PEG was selected as the water extractable porogen to 
make the porous PLGA  microspheres [17].  Figure 1 
shows the morphological change of PLGA microspheres 
from a non-porous to an open cellular porous structure with 
increasing weight ratio of PEG/PLGA. Morphologically, 
SEM revealed that control microspheres showed a 
smooth, nonporous surface while the microspheres with 
PEG exhibited a highly porous surface. 
The porosity of microspheres increased with an 
increasing amount of PEG. The reason for selecting 
PEG is that it is an uncharged, linear and hydrophilic 
and easily extractable in aqueous phase. For preparing 
the porous microspheres, a blend mixture of PEG 
and PLGA was co-dissolved in a disperse phase of 
methylene chloride (MC), and the volatile solvent was 
slowly removed from the embryonic MC droplets within 
the aqueous continuous phase. As the embryonic MC 
droplets containing PEG and PLGA were in contact with 
aqueous phase, the influx of water and concomitant out 
flux of MC caused a phase separation, giving rise to a 
PLGA-rich phase and a PEG-rich phase [18]. During 
solvent removal, water-soluble PEG was also leached 
out into the outer aqueous phase, therefore sufficient 
MC removal produced a porous skeletal structure of 
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E =  x 100
 amount of encapsulated protein
    total amount of feed protein      
channels. This swollen polymer structure is expected 
to increase exchange of polymer degradation products 
with the surrounding medium, minimizing the risk of acid 
induced protein degradation [19].
It can be seen in Figure 2 that the average diameter of 
porous microspheres increased from 9.38 μm - to 38.9 
μm while that of the size of surface pores increases from 
0-2.64 μm with increasing weight ratio of PEG/PLGA. 
This results from increasing the fractional volume of the 
hydrophilic PEG phase within the blend mixture, which in 
turn imbibes more water into the droplets, enlarging the 
size of embryonic MC droplets. The hardening of these 
  
Fig. 2. The average diameter of microspheres and 
surface pores as function of PEG/PLGA weight ratio. 
Each bar is the mean of ± standard deviation of at least 
three experiments. The error bars indicate the standard 
deviation between the averages.
droplets produced larger microspheres. PVA 
concentration in the external water phase is known to be 
a factor that influences the size of microspheres. In the 
present study, the porous microspheres were prepared 
by varying the concentration of PVA solution. Fixing the 
weight ratio of PEG/PLGA at 20/80, the concentration 
of PVA solution varied from 0.5% to 4%. As the 
concentration of PVA solution increasing, the mean size 
decreased from 38.9 μm to 22.6 μm. The effect of PVA 
concentration the volume mean diameter is shown in 
Table 1. The decrease in particle size of microspheres 
was occurred because that the viscosity of PVA solution
Table 1. Variation in PEG/PLGA microspheres size as a 
function of PVA concentration in the emulsion water phase.
increased as the concentration increased, which affects 
the dispersibility of emulsion droplets in the continuous 
phase and efflux velocity of PEG phase. The stirring 
speed of the dispersive process was a key factor to affect 
the morphology of porous microspheres. It was found 
that the high stirring speed would destroy the spherical 





0.5 16.06 38.9 70.2
1.0 8.24 31.8 67.2
2.0 4.55 27.8 76.7
3.0 7.69 30.7 70.3
4.0 4.03 23.6 68.28
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     0/100  20/80
          50/50 80/20
structure of porous microspheres and formed sponge-
like structures with irregular shape. It was because that 
porous structure had degraded the mechanical property 
of the microspheres system.The spherical structure of 
microspheres would be destroyed during stirring, which 
could provide the shearing force to destroy the system 
(Figure 3).
In conclusion, porous microspheres with a highly 
interconnecting pores and large porous surface were 
prepared with this condition in further study. The process 
conditions optimized at 80/20 PEG/PLGA weight ratio, 
PVA solution concentration 0.5% and 3% MC/water 
volume ratio gave production of the porous PLGA 
microspheres with interconnected pores. Using these 
porous PLGA microspheres, we intended to achieve 
sustained release of protein drugs. In many cases, 
proteins have been encapsulated with in biodegradable 
microspheres by a double emulsion W/O/W technique 
because of their limited solubility in organic solvents. 
Although the use of organic solvents in the formula-
tion process deactivates biological activity of the 
encapsulated protein to a great extent, they are 
unavoidably required to prepare the protein encapsulated 
PLGA microspheres [20]. Klibanov and co-workers 
have shown that the conformation of solid proteins in 
organic solvents is kinetically trapped [21]. Thus, protein 
unfolding is extremely slow under these preparation 
conditions. Problems may arise, however, when the 
protein (partially) dissolves in the organic phase. The 
latter often results in unfolding [22, 23]. In this study, 
lysozyme was loaded into porous microspheres by a 
simple solution immersing method without any harsh 
preparation conditions, such as the aqueous/organic 
interface produced by a water-in-oil microemulsion and 
the acute shearing strength brought by a high-speed 
homogenizer or a sonicater. Thus, protein denaturation 
and aggregation happened on aqueous/organic interface 
can be avoided in loading process.  Protein loading on 
biomaterials is a complicated physiochemical process 
and has widely researched. In this study, the effect of 
loading temperature and incubation time on lysozyme 
into porous microspheres were examined. Protein 
loading was carried out at 4°C in this study, which was a 
mild environment for protein activity. The protein loading 
increased with increasing incubation time.
Fig. 4. Time dependent loading efficiency.
Shown in Figure 4, the adsorption amount of lysozyme 
almost reached the zenith and kept stable value 
after 6 hours. Then the suspension was treated with 
water-miscible solvents in aqueous solution to close 
the pores. Attempts for closing the pores were tried by 
using water-miscible solvents that partially dissolved
PLGA. Figure 5 shows pore-closed of blank porous 
PLGA microspheres treated with an aqueous solutions 
 Fig. 3. Destroyed porous microspheres during stirring 
process.
Fig. 5. SEM images of open/closed PLGA microspheres PEG/PLGA porous microspheres at ratio of 80:20 were treated 
with different aqueous solutions at suitable concentration (v/v). a. DMSO 20%, b. DMF 20%, c. EtOH 30%.
 a  b  c
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containing different concentrations. It can be seen that 
the surfaces pores are gradually closed with increasing 
the water miscible solvent/water volume ratio. Moreover, 
the pore closed microspheres did not aggregate and 
were able to maintain its spherical shape. Particularly, 
ethanol does not completely dissolve the raw PLGA 
particles to a clear solution state, but makes them 
swell into rubbery and sticky state. An ethanol volume 
fraction at 30% produced nonporous microspheres. The 
increased volume fraction of ethanol in aqueous phase 
caused to partially dissolve PLGA skeletal structure of 
porous microspheres to collapse, and unlimitedly closed 
the pores by fusion of the surrounding PLGA polymer 
phase. When the ethanol/water volume ratio was 
over 30%, most of the microspheres were aggregated 
and precipitated due to collision-induced fusion of 
partially dissolved porous microspheres (Figure 6).
Protein release from polymeric microspheres was 
depending on degradation of polymers and the protein 
diffusion out from microspheres [23]. 
Generally, these two ways happened at same time in 
release process. Therefore, the release curve was made 
up of two phases, the burst release followed by a stable 
release stage. In the burst release phase, the protein
adsorbed on the surface of microspheres diffused out 
quickly first few hours. Burst release was not beneficial 
to patients who needed long term treatments. Seen from 
Figure 7, it can be found that 88.7% of lysozyme loading 
in the porous microspheres was released at first day. 
In the case of porous microspheres, most of the 
loaded protein immediately diffused out through 
water-filled porous and inter connected channels, 
as expected, the initial burst showed high percent.
On the other hand, pore closed microspheres showed 
much slower release patterns, caused by the creation 
of a diffusion barrier to the encapsulated protein. 
The closed surface pores resulted in reduced diffusion 
rates of encapsulated protein as shown in Figure 7.
Fig. 6. Partially dissolved porous microspheres
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Fig. 7. In vitro release of lysozyme from porous and pore 
closed microspheres. Each bar is the mean of three 
experiments ± standard deviation
 a  b  c
 d  e  f
Fig. 8. The morphological changes of microspheres during degradation processing detected by SEM. Porous PLGA 
microspheres (a-c) and porous microspheres treated by ethanol (d-f) degradated for 1, 3 and 5 weeks, respectively.
The initial burst was also greatly reduced from 85.6% ± 
2.5 to 26.3% ±1.1. In this study, protein was loaded with 
in porous microspheres by a simple immersing process, 
thus avoiding the solvent/water interface problem during 
formulation. However, the pore closed microspheres 
prepared by treating with the water miscible solvent had 
a serious shortcoming: insufficient drug loading amount. 
Although the porous microspheres showed high of initial 
drug loading amount, nonporous microspheres produced 
by the solvent treatment showed sharp decrease in 
drug loading amount. Entrapped hydrophilic molecules 
within the porous microspheres were quickly dissolved 
and diffused out to the outer aqueous phase before 
the pore closing process took place. Microspheres 
surface charge density was modified successfully using 
PLGA and Polyelectrolyte polymer blends, and these 
microspheres were used to investigate the loading 
capacity of lysozyme, a model electropositive protein. 
Furthermore, it is noteworthy mention that the protein 
maintained its structural integrity after this preparation. 
In order to investigate the degradation of microspheres, 
the change in surface morphology of the pore closed 
microspheres with time after incubation with PBS, porous 
microspheres as a control. The morphological change 
of porous microspheres and pore closed microspheres 
during degradation process was shown in Figure 8.
The surface morphology of porous microspheres in 
degradation of 1, 3 and 5 weeks were shown in Figure 
8(a), (b) and (c) respectively. The porous microspheres 
lost their spherical structure in 1 week degradation. 
This fast deformation was due to the porous structure, 
which made water penetrate into the microspheres 
matrix easily and the hydrolysis was the dominant 
way in polymer degradation. After 5 weeks the porous 
microspheres were totally collapsed. While, the pore 
closed microspheres retained their spherical structures 
in 1 week degradation, shown in Figure 8(d). 
The pore closed microspheres collapsed and lost their 
spherical structure after 3 weeks degradation as shown 
in Figure 8(e). In conclusion, the morphological change 
of porous microspheres was faster than pore closed 
microspheres. 
CONCLUSIONS
Porous PLGA microspheres were prepared by a single-oil-
water emulsion method using PEG as water extractable 
porogen. The weight ratio of PEG/PLGA and MC/water 
volume ratio were two of the most important factors in 
determining the size of microspheres, pore diameter and 
their morphology. The resulting interconnected porous 
microspheres were readily transformed to nonporous 
microspheres by treating with water-miscible solvents 
under aqueous conditions. When protein was loaded 
within porous microspheres by an aqueous immersing 
method, careful selection of water-miscible solvents 
was necessary for effective pore closing process. The 
resultant nonporous microspheres exhibited sustained 
release profiles over and extended period, but the drug 
loading amount was not satisfactory and subject to 
further study. 
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